1. Home
  2. CABA vs NVEC Comparison

CABA vs NVEC Comparison

Compare CABA & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$3.39

Market Cap

319.6M

Sector

Health Care

ML Signal

HOLD

Logo NVE Corporation

NVEC

NVE Corporation

HOLD

Current Price

$78.27

Market Cap

335.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
NVEC
Founded
2017
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
319.6M
335.8M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
CABA
NVEC
Price
$3.39
$78.27
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
1.9M
34.4K
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
5.22%
EPS Growth
10.26
N/A
EPS
N/A
2.12
Revenue
N/A
$25,874,694.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$36.15
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$55.48
52 Week High
$3.78
$82.30

Technical Indicators

Market Signals
Indicator
CABA
NVEC
Relative Strength Index (RSI) 63.99 75.68
Support Level $2.32 $64.17
Resistance Level $3.73 $82.09
Average True Range (ATR) 0.20 2.13
MACD 0.06 1.11
Stochastic Oscillator 99.48 99.90

Price Performance

Historical Comparison
CABA
NVEC

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: